govt.fyi
Back to H.R. 586
US Congress· H.R. 586Passed the House

Vietnam Veterans Liver Fluke Cancer Study Act, the official text

Shown verbatim as published by GovInfo, version rfs (Referred in Senate), captured 2026-07-23. Page markers and notes are part of the official record; nothing is edited or removed. This version at GovInfo.
119 HR 586 : Vietnam Veterans Liver Fluke Cancer Study Act
U.S. House of Representatives
2025-04-08
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
IIB 119th CONGRESS 1st Session H. R. 586 IN THE SENATE OF THE UNITED STATES April 8, 2025 Received; read twice and referred to the Committee on Veterans' Affairs
AN ACT To direct the Secretary of Veterans Affairs to study and report on the prevalence of cholangiocarcinoma in veterans who served in the Vietnam theater of operations during the Vietnam era, and for other purposes. 1. Short title
This Act may be cited as the Vietnam Veterans Liver Fluke Cancer Study Act .
2. Study on the prevalence of cholangiocarcinoma in veterans who served in the Vietnam theater of operations during the Vietnam era
(a) Epidemiological study
Not later than 120 days after the date of enactment of this Act, the Secretary of Veterans Affairs, in consultation with the Director of the Centers for Disease Control and Prevention of the Department of Health and Human Services, shall commence an epidemiological study on the prevalence of cholangiocarcinoma in covered veterans of the Vietnam era, using data from the Veterans Affairs Central Cancer Registry and the National Program of Cancer Registries. The study shall include—
(1) an identification of the rate of incidence of cholangiocarcinoma in covered veterans of the Vietnam era and in residents of the United States, from the beginning of the Vietnam era to the date of enactment of this Act; and
(2) for each of the groups specified in paragraph (1), an identification of the percentage of individuals with cholangiocarcinoma by various demographic characteristics, including by age, gender, race, ethnicity, and the geographic location of the patient at the time of diagnosis.
(b) Reports to Congress
(1) Initial report
Not later than one year after the completion of the study under subsection (a), the Secretary shall submit to Congress a report containing—
(A) the results of the study under subsection (a); and
(B) recommendations for administrative or legislative actions required to address issues identified in the study under subsection (a).
(2) Follow-Up reports
The Secretary shall periodically submit to the Congress a follow-up reports, as determined by the Secretary, to provide updates to the information included in the initial report under paragraph (1) and information collected pursuant to subsection (c).
(c) Continued tracking of cholangiocarcinoma in covered veterans of the Vietnam era
The Secretary shall track the prevalence of cholangiocarcinoma in covered veterans of the Vietnam era using the Veterans Affairs Central Cancer Registry, and provide such information to Congress in follow-up reports submitted under subsection (b)(2).
(d) Definitions
In this section:
(1) The term Vietnam era has the meaning given such term in section 101 of title 38, United States Code.
(2) The term covered veterans of the Vietnam era means veterans who served in the Vietnam theater of operations during the Vietnam era.
3. Extension of certain limitation of pension payments
Section 5503(d)(7) of title 38, United States Code, is amended by striking November 30, 2031 and inserting December 31, 2031 .
Passed the House of Representatives April 7, 2025. Kevin F. McCumber, Clerk.
Every fact on this page links to its source, starting with the official bill record.